Precision and Personalized Medicine For Life Sciences

June 8-9, 2022 | VIRTUAL EVENT

Precision and Personalized Medicine For Life Sciences

This science is all about patient
and payer outcomes

This science is all about patient and payer outcomes

In the current medical era, where innovation and efficiency are critical forces to success, the adoption of personalized/precision medicine initiatives is the next step in advancing quality care, better patient outcomes, and higher payer satisfaction. Through the proper usage of genetic testing and a better understanding of biomarker indicators, precision medicine can be utilized to prevent diseases in high risk patients, increase HCP efficiency, and an increase in therapy cost effectiveness to better satisfy payers.

Despite these positive benefits, the adoption of these initiatives has been slow and there are still barriers to success. In many instances, there are not enough people to process the mass amount of information these data driven sciences create or critical patient data is either incomplete or inaccurate because of a reliance on digital tools for data collection.

Precision Medicine is still a developing medical science, but it has the potential to add lifesaving initiatives to many aspects of the pharma field. If genetic testing and biomarker indication techniques are used properly and on the right people, a massive impact can be made in the area of disease prevention.

SPEAKERS HIGHLIGHTS

Richard Batchelder
Richard Batchelder

Global Director
Commercial Personalized Medicine
Market Development

GENENTECH/ROCHE

Shrividya Iyer
Shrividya Iyer
Executive Director, Oncology Global Real World Evidence (RWE) & US HEOR

EISAI US

Amy Gorman
Amy Gorman
Global Precision Medicine Commercial Strategy Director

JANSSEN

Andrea Stevens
Andrea Stevens
Director, Precision Medicine Access Strategy Global Commercial Data Science

JANSSEN

Claudia Dollins
Claudia Dollins
Comparative Diagnostics and Precision Medicine, Executive Director, Regulatory Affairs

BRISTOL-MYERS SQUIBB

Naveen Babbar
Naveen Babbar
Senior VP, Translational Medicine

PRELUDE THERAPEUTICS

Dr. Nita Limdi
Dr. Nita Limdi

Associate Director
Hugh Kaul Precision
Medicine Institute

UAB

Nikki Martin
Nikki Martin

Director of Precision
Medicine Initiatives

THE LUNGEVITY FOUNDATION

Ruth Nussinov
Ruth Nussinov
Head, Computational Biology Section

NATIONAL INSTITUTE OF HEALTH

TOP REASONS TO ATTEND

  • Analyze how novel, innovative, and creative data driven medical systems are being developed to better patient outcomes and payer satisfaction
  • Overcome common barriers to precision medicine acceptance and increase widespread adoption throughout your medical and commercial enterprise
  • Understand how to integrate new, data driven sciences that increase HCP efficiency and improved patient outcomes on your brand therapeutic
  • Review the latest achievements from top academic researchers and the impact these research studies will have on the future of precision medicine in the pharma business model
  • Examine new patient care models and how best to convey their importance to both payer and HCP
  • Build on knowledge of essential biomarker and geno-type based therapies and how best to apply them to current care models
  • Gain an understanding of the future of pharmacogenomics and pharmacogenetics testing and the advantages to utilizing this advancing medical science within precision medicine

Who Should Attend

Primary Market:

  • Personalized Healthcare/Medicine
  • Precision Medicine/healthcare
  • Translational Health/Medicine
  • Diagnostic and Personalized Medicine R&D
  • Combination Product R&D
  • Quality Assurance and Control
  • Submissions
  • Genomics
  • RWE
  • Informatics
  • Digital Health 
  • Digital Innovation 
  • Digital Medicine
  • AI
  • Bioinformatics
  • Patient Solutions 
  • Patient Engagement 
  • Clinical Innovation 
  • Clinical Operations

Secondary Market:

  • Digital Health Providers 
  • Translational Medicine Consultancies (e.g. Mckinsey and other large firms)
  • Physician Networks 
  • Medical Diagnostics and Early Phase Testing Companies 
  • Digital Agencies 
  • Technology Providers 
  • Clinical Technology and Data Management Solution Providers 
  • Functional Service Provider

Interested in Sponsorship Opportunities?

Please contact Meg Larson at Meg@momentumevents.com

NETWORKING CAPABILITIES

Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform’s matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services

Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers

The platform we use allows us to make polls, QA, and chat during the sessions.

How Will The Virtual Event Work

Designed to provide a fully immersive experience that expands beyond the traditional video conferencing platform, Momemtum Virtual Events take place on a platform that includes the latest advancements to deliver a seamless and simple user interface to increase engagement across all participants.

  • Exclusive event hub page accessible via desktop, tablet or mobile device
  • Virtual lobby with topic streams that creates a “community” atmosphere
  • Dedicated live stream session content
  • Live Q&A & Interactive Polling
  • Embedded AI powered match-making 1:1 meeting facilitation
  • Embedded video and/ or audio chat
  • Direct messaging
  • And much more…